DE602006020781D1 - T-helper antigenic determinant (thd) peptide - Google Patents

T-helper antigenic determinant (thd) peptide

Info

Publication number
DE602006020781D1
DE602006020781D1 DE602006020781T DE602006020781T DE602006020781D1 DE 602006020781 D1 DE602006020781 D1 DE 602006020781D1 DE 602006020781 T DE602006020781 T DE 602006020781T DE 602006020781 T DE602006020781 T DE 602006020781T DE 602006020781 D1 DE602006020781 D1 DE 602006020781D1
Authority
DE
Germany
Prior art keywords
peptide
thd
antigenic determinant
helper
helper antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006020781T
Other languages
German (de)
English (en)
Inventor
Cuesta Francisco Borras
Sagastibelza Juan Jose Lasarte
Egozcue Marta Ruiz
Ugarriza Pablo Sarobe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proyecto de Biomedicina CIMA SL
Original Assignee
Proyecto de Biomedicina CIMA SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proyecto de Biomedicina CIMA SL filed Critical Proyecto de Biomedicina CIMA SL
Publication of DE602006020781D1 publication Critical patent/DE602006020781D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602006020781T 2005-12-23 2006-12-19 T-helper antigenic determinant (thd) peptide Active DE602006020781D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503169A ES2310072B1 (es) 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
PCT/ES2006/000695 WO2007074188A1 (es) 2005-12-23 2006-12-19 NUEVOS PEPTIDOS DETERMINANTES ANTIGENICOS T COLABORADORES (DTh)

Publications (1)

Publication Number Publication Date
DE602006020781D1 true DE602006020781D1 (en) 2011-04-28

Family

ID=38217710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020781T Active DE602006020781D1 (en) 2005-12-23 2006-12-19 T-helper antigenic determinant (thd) peptide

Country Status (12)

Country Link
US (1) US20090220533A1 (enExample)
EP (1) EP1978026B1 (enExample)
JP (1) JP2009520772A (enExample)
CN (1) CN101374857A (enExample)
AT (1) ATE502047T1 (enExample)
AU (1) AU2006329789A1 (enExample)
BR (1) BRPI0620243A2 (enExample)
CA (1) CA2634840A1 (enExample)
DE (1) DE602006020781D1 (enExample)
ES (1) ES2310072B1 (enExample)
RU (1) RU2008129731A (enExample)
WO (1) WO2007074188A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2784189T3 (es) 2009-03-27 2020-09-23 Academia Sinica Métodos y composiciones para la inmunización contra virus
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0735893T3 (da) * 1993-09-14 2009-03-09 Pharmexa Inc PAN DR-bindende peptider til styrkelse af immunsvaret
DE69714011T2 (de) 1996-01-24 2003-02-27 Epimmune, Inc. Die erzeugung einer immunantwort gegen erwünschte determinanten
US6413517B1 (en) * 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
AU4224499A (en) * 1998-05-29 1999-12-13 Epimmune, Inc. Identification of broadly reactive dr restricted epitopes
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
US20040236514A1 (en) * 2001-12-13 2004-11-25 Lee Stephen C. Controlling distribution of epitopes in polypeptide sequences

Also Published As

Publication number Publication date
BRPI0620243A2 (pt) 2011-11-08
ES2310072A1 (es) 2008-12-16
US20090220533A1 (en) 2009-09-03
ES2310072B1 (es) 2009-11-16
ATE502047T1 (de) 2011-04-15
EP1978026A1 (en) 2008-10-08
WO2007074188A1 (es) 2007-07-05
EP1978026A4 (en) 2010-03-10
CN101374857A (zh) 2009-02-25
CA2634840A1 (en) 2007-07-05
JP2009520772A (ja) 2009-05-28
EP1978026B1 (en) 2011-03-16
AU2006329789A1 (en) 2007-07-05
RU2008129731A (ru) 2010-01-27

Similar Documents

Publication Publication Date Title
TW200505837A (en) Novel compounds
TW200519075A (en) Novel compounds
ATE523514T1 (de) Tricyclische triazolische verbindungen
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
TW200732296A (en) Novel compounds
MX336807B (es) Composiciones y metodos para producir una composicion.
MX2007006179A (es) Tetrahidrocarbazoles como agentes activos para inhibir la produccion del factor de crecimiento endotelial vascular por control de la traduccion.
TW200800999A (en) Novel compounds
TW200626171A (en) Fixed dosing of HER antibodies
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
TNSN07222A1 (en) Nematicidal compositions
SG170086A1 (en) Modified molecules which promote hematopoiesis
DK2018169T3 (da) Anvendelse af 4,17-beta-dihydroxyandrost-4-en-3-on til behandling af cancer
WO2007052023A3 (en) Novel compounds
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
BRPI0414008B8 (pt) compostos que se ligam a um receptor de trombopoietina, composições e métodos in vitro para ativação de um receptor de trombopoietina em uma célula
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
DE602006019732D1 (de) Indolylmaleimidderivate
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
PL1856093T3 (pl) Chlorowodorek (2R,4aR,10bR)-6-(2,6-dimetoksy-pirydyn-3-ylo)-9-etoksy-8-metoksy-1,2,3,4,4a,10b-heksahydrofenantrydyn-2-olu
DE602006020781D1 (en) T-helper antigenic determinant (thd) peptide
SI1797022T1 (sl) Postopki za čiščenje radiomarkiranih produktov z uporabo lovilnega sredstva na trdnem nosilcu
SI1720540T1 (sl) Satraplatin za zdravljenje rezistentnih ali refraktornih tumorjev